Clinical trial
Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide
NCT00381589 · Centre for Addiction and Mental Health, Other · Completed
Key facts
| NCT number | NCT00381589 |
|---|---|
| Title | Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide |
| Official title | Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide |
| Lead sponsor | Centre for Addiction and Mental Health, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hypersalivation |
| Intervention type | Drug |
| Interventions | ipratropium bromide 0.03% spray |
| Enrollment | 25 |
| Start date | Oct 1, 2006 |
| Primary completion | Jun 1, 2008 |
| First posted | Sep 28, 2006 |
| Last update posted | Feb 12, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: